Welcome to LookChem.com Sign In|Join Free

CAS

  • or

926220-09-9

Post Buying Request

926220-09-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

926220-09-9 Usage

Chemical composition

Benzoic acid molecule attached to a phenyl ring with a trifluoromethoxy group

Uses

Building block for the synthesis of pharmaceutical compounds, potential anti-inflammatory and analgesic properties

Characteristics

Highly stable, low toxicity, valuable tool for chemical research and drug discovery

Check Digit Verification of cas no

The CAS Registry Mumber 926220-09-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,6,2,2 and 0 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 926220-09:
(8*9)+(7*2)+(6*6)+(5*2)+(4*2)+(3*0)+(2*0)+(1*9)=149
149 % 10 = 9
So 926220-09-9 is a valid CAS Registry Number.

926220-09-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-[2-(trifluoromethoxy)phenyl]benzoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:926220-09-9 SDS

926220-09-9Upstream product

926220-09-9Downstream Products

926220-09-9Relevant articles and documents

PYRROLIDINE OR THIAZOLIDINE CARBOXYLIC ACID DERIVATIVES, PHARMACEUTICAL COMPOSITION AND METHODS FOR USE IN TREATING METABOLIC DISORDERSAS AS AGONISTS OF G- PROTEIN COUPLED RECEPTOR 43 (GPR43)

-

Page/Page column 203, (2011/07/07)

The present invention is directed to novel compounds of formula (I) and their use in treating and/or preventing metabolic diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 926220-09-9